Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products
The Power List 2022 focuses on the top 10 VIPs in three key categories of medicine making
Antibody drug conjugates are starting to transform cancer treatments, so let’s maintain the momentum.
In a market filled with complexity, working with a single supplier simplifies the supply chain and focuses effort towards a single target.
A Korean team have conducted a study on a peptide that could help to produce medicines capable of crossing cell membranes and interfering with PPIs.
Our Innovation Awards will celebrate the highest-impact pharma development and manufacturing technologies released during 2021.
DFE Pharma’s Korinde Van Den Heuvel talks to us about what made her company’s new 3D printed tablets possible, and which ills they can cure.
A pill developed at MIT and inspired by tortoises could replace injections for monoclonal antibody therapies.
How is the field of antibody drug conjugates being reshaped?
An institute for the gifted with X in its name, presided over by a wise doctor, has launched two new projects. Somebody call Magneto!
Embracing the benefits of auto-injectors.
Inhalers still don’t work as well as they should, but computational modeling is here to help.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
A Tale of Two Continents
The Early Bird Gets the…
Words With the Fearless Leader